Moderna stock surges after company announces promising coronavirus vaccine trial data – CNBC

Modernas stock rose 12% on Wednesday after the biotech business launched appealing data on its prospective coronavirus vaccine trial, stating it created a “robust” immune response..
The vaccine can … [+5401 chars]